EP2815238A4 - A process for detection and optional quantification of an analyte - Google Patents
A process for detection and optional quantification of an analyte Download PDFInfo
- Publication number
- EP2815238A4 EP2815238A4 EP13749422.5A EP13749422A EP2815238A4 EP 2815238 A4 EP2815238 A4 EP 2815238A4 EP 13749422 A EP13749422 A EP 13749422A EP 2815238 A4 EP2815238 A4 EP 2815238A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- analyte
- detection
- optional quantification
- quantification
- optional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012491 analyte Substances 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000011002 quantification Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN566CH2012 | 2012-02-15 | ||
PCT/IB2013/051193 WO2013121368A2 (en) | 2012-02-15 | 2013-02-14 | A process for detection and optional quantification of an analyte |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2815238A2 EP2815238A2 (en) | 2014-12-24 |
EP2815238A4 true EP2815238A4 (en) | 2017-05-03 |
EP2815238B1 EP2815238B1 (en) | 2020-04-08 |
Family
ID=48984858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13749422.5A Active EP2815238B1 (en) | 2012-02-15 | 2013-02-14 | A process for detection and optional quantification of an analyte |
Country Status (7)
Country | Link |
---|---|
US (1) | US9638696B2 (en) |
EP (1) | EP2815238B1 (en) |
KR (1) | KR102076354B1 (en) |
AU (1) | AU2013219968B2 (en) |
ES (1) | ES2796253T3 (en) |
NZ (1) | NZ700025A (en) |
WO (1) | WO2013121368A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015138702A1 (en) * | 2014-03-13 | 2015-09-17 | Pharmacophotonics, Inc. D/B/A Fast Biomedical | Improved measurement of body fluid volumes |
EP2904393B1 (en) * | 2012-10-03 | 2018-11-28 | Gyros Patent Ab | Method and kit for analyte determination at acidic conditions |
EP3304084B1 (en) | 2015-06-08 | 2022-03-23 | Arquer Diagnostics Limited | Methods and kits |
CN107771285A (en) | 2015-06-08 | 2018-03-06 | 阿奎尔诊断有限公司 | Method |
US10027165B2 (en) * | 2016-06-20 | 2018-07-17 | Fairchild Semiconductor Corporation | Power supply circuit with secondary side to primary side communication |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4604348A (en) * | 1981-11-19 | 1986-08-05 | New York Blood Center, Inc. | Composition for use in immunoassays |
US5641640A (en) * | 1992-06-29 | 1997-06-24 | Biacore Ab | Method of assaying for an analyte using surface plasmon resonance |
US20080182796A1 (en) * | 2001-08-31 | 2008-07-31 | Syngenta Participations Ag | Modified Cry3A toxins and nucleic acid sequences coding therefor |
US20110177095A1 (en) * | 2009-12-16 | 2011-07-21 | Abbott Biotherapeutics Corporation | Anti-her2 antibodies and their uses |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657851A (en) * | 1984-01-03 | 1987-04-14 | Georgetown University | Breast cancer diagnostic blood test |
US5256541A (en) * | 1991-11-06 | 1993-10-26 | Sangstat Medical Corporation | Detection of soluble alloantigen immune complexes |
DE19538641C2 (en) * | 1995-10-05 | 2000-09-21 | Privates Inst Bioserv Gmbh | Patient-specific immunoadsorbents for extracorporeal apheresis and processes for their production |
US20030125536A1 (en) * | 1996-01-11 | 2003-07-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
DE19963859A1 (en) * | 1999-12-30 | 2001-07-12 | Apotech Res & Dev Ltd | Bi- or oligomer of a di-, tri-, quattro- or pentamer of recombinant fusion proteins |
US6984494B2 (en) * | 2000-08-15 | 2006-01-10 | Genentech, Inc. | Analytical method |
-
2013
- 2013-02-14 AU AU2013219968A patent/AU2013219968B2/en active Active
- 2013-02-14 NZ NZ700025A patent/NZ700025A/en active IP Right Revival
- 2013-02-14 KR KR1020147025748A patent/KR102076354B1/en active IP Right Grant
- 2013-02-14 WO PCT/IB2013/051193 patent/WO2013121368A2/en active Application Filing
- 2013-02-14 EP EP13749422.5A patent/EP2815238B1/en active Active
- 2013-02-14 US US14/379,186 patent/US9638696B2/en active Active
- 2013-02-14 ES ES13749422T patent/ES2796253T3/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4604348A (en) * | 1981-11-19 | 1986-08-05 | New York Blood Center, Inc. | Composition for use in immunoassays |
US5641640A (en) * | 1992-06-29 | 1997-06-24 | Biacore Ab | Method of assaying for an analyte using surface plasmon resonance |
US20080182796A1 (en) * | 2001-08-31 | 2008-07-31 | Syngenta Participations Ag | Modified Cry3A toxins and nucleic acid sequences coding therefor |
US20110177095A1 (en) * | 2009-12-16 | 2011-07-21 | Abbott Biotherapeutics Corporation | Anti-her2 antibodies and their uses |
Non-Patent Citations (1)
Title |
---|
LEE JEAN W ET AL: "Bioanalytical Approaches to Quantify Total and Free Therapeutic Antibodies and Their Targets: Technical Challenges and PK/PD Applications Over the Course of Drug Development", THE AAPS JOURNAL, SPRINGER US, BOSTON, vol. 13, no. 1, 15 January 2011 (2011-01-15), pages 99 - 110, XP035719169, DOI: 10.1208/S12248-011-9251-3 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013121368A3 (en) | 2016-07-07 |
KR102076354B1 (en) | 2020-02-10 |
WO2013121368A2 (en) | 2013-08-22 |
EP2815238B1 (en) | 2020-04-08 |
AU2013219968A1 (en) | 2014-10-02 |
EP2815238A2 (en) | 2014-12-24 |
NZ700025A (en) | 2018-07-27 |
KR20150034676A (en) | 2015-04-03 |
US9638696B2 (en) | 2017-05-02 |
AU2013219968B2 (en) | 2018-11-08 |
US20160003826A1 (en) | 2016-01-07 |
ES2796253T3 (en) | 2020-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1207422A1 (en) | Device and method for detection of analytes | |
HK1204648A1 (en) | Methods and devices for detection and measurement of analytes | |
EP2839296A4 (en) | Method for the detection and quantification of analytes using three-dimensional paper-based devices | |
HK1209830A1 (en) | Systems and methods for detection and quantification of analytes | |
HK1212932A1 (en) | Methods and devices for detection and acquisition of biomarkers | |
EP3425063C0 (en) | Methods for analyte detection | |
EP2741271B8 (en) | Object detector and object detection method | |
GB201120965D0 (en) | System and method for detection of analytes | |
EP2680247A4 (en) | Periodic stationary object detection device and periodic stationary object detection method | |
GB201115120D0 (en) | Method and device for detecting an analyte | |
HK1198705A1 (en) | Apparatus and methods for detecting analytes | |
EP2596899B8 (en) | Method and device for the interference structuring of flat samples | |
EP2680011A4 (en) | Measurement device and measurement method | |
EP3055687A4 (en) | An apparatus and associated methods for analyte detection | |
GB201002627D0 (en) | Aptamer based analyte detection method | |
EP2696165B8 (en) | Wrinkle detection device and wrinkle detection method | |
EP2815238A4 (en) | A process for detection and optional quantification of an analyte | |
EP3435082B8 (en) | Detection of multiple analytes | |
EP3030892A4 (en) | An apparatus and associated methods for analyte detection | |
PL2823309T3 (en) | Method and device for detecting analytes | |
EP2687834B8 (en) | Measuring instrument and method for measuring an applied force | |
EP2665036A4 (en) | Detection device and detection method | |
EP2734844A4 (en) | Method for the detection of an analyte in a sample | |
AU2011900192A0 (en) | Method and apparatus for conducting an assay with improved detection | |
AU2012904403A0 (en) | Apparatus and method of detecting wear |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20140911 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
R17D | Deferred search report published (corrected) |
Effective date: 20160707 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20170404 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/68 20060101ALI20170329BHEP Ipc: G01N 33/53 20060101AFI20170329BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180315 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20190925 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1255089 Country of ref document: AT Kind code of ref document: T Effective date: 20200415 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602013067701 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200408 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200708 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200808 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200709 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200817 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1255089 Country of ref document: AT Kind code of ref document: T Effective date: 20200408 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2796253 Country of ref document: ES Kind code of ref document: T3 Effective date: 20201126 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200708 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013067701 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 |
|
26N | No opposition filed |
Effective date: 20210112 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20210228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210228 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210228 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210214 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210214 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210228 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230123 Year of fee payment: 11 Ref country code: ES Payment date: 20230310 Year of fee payment: 11 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20130214 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230126 Year of fee payment: 11 Ref country code: GB Payment date: 20230119 Year of fee payment: 11 Ref country code: DE Payment date: 20230117 Year of fee payment: 11 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200408 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230526 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602013067701 Country of ref document: DE Owner name: BIOSIMILARS NEW CO. LTD., GB Free format text: FORMER OWNERS: BIOCON LIMITED, BANGALORE, KARNATAKA, IN; MYLAN GMBH, ZUERICH, CH |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20230928 AND 20231004 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240306 Year of fee payment: 12 |